Log in to your Inderes Free account to see all free content on this page.

Probi

Less than 1K followers

All

Webcasts

Press releases

3rd party

ShowingAll content types

Press release7/22/2025, 1:00 PM

Women's Health by Probi wins NutraIngredients-USA Award for Innovation in Women's Health

Press release5/28/2025, 6:37 AM

Probi Female wins prestigious NutraIngredients Award 2025 for innovation in women's health

Press release5/7/2025, 12:30 AM

First-of-its-kind: Nomura Dairy and Probi[ ]introduce probiotic-enhanced carrot juice to Japan

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release2/3/2025, 8:20 AM

Delisting of Probi

Regulatory press release1/20/2025, 9:01 PM

Notice of Extraordinary General Meeting in Probi AB (publ)

Regulatory press release1/20/2025, 9:00 PM

Probi applies for delisting and convenes an Extraordinary General Meeting

Regulatory press release1/9/2025, 7:00 AM

Probi postpones year-end report 2024

Regulatory press release12/13/2024, 4:17 PM

Statement from the independent bid committee of Probi in relation to the public takeover offer by Symrise

Regulatory press release11/20/2024, 6:19 AM

Probi's Board comments on Symrise's public takeover offer

Regulatory press release11/13/2024, 10:00 AM

Probi CFO departure

Press release10/23/2024, 11:00 AM

Probi Launches Clinically-Supported Probiotic Solution for Metabolic Health at SupplySide West 2024

Third party research10/23/2024, 5:24 AM

Probi: Managing costs well in Q3 - ABG

Miss on Q3 sales (-12%) and EBITDA (-10%) vs ABGSCe China faced headwinds due to macroeconomic factors EBITDA revised down by 2-3% for '24e-'26e Encouraging B2C sales efforts in the Nordics Probi reported a soft Q3'24 with sales amounting to SEK 143....

Probi, Audiocast with teleconference, Q3'24

Webcast10/22/2024, 8:00 AM

Probi, Audiocast with teleconference, Q3'24

Regulatory press release10/22/2024, 6:00 AM

Probi: Q3 2024: Tangible improvement in operations

Press release10/17/2024, 6:50 AM

Presentation of Probi's Q3 Report 2024

Press release10/16/2024, 11:30 AM

Probi partners with Global BHP BrainTrust and the FINGERS Brain Health Institute to counteract dementia

Press release10/10/2024, 7:00 AM

Nordic launch of Probi Sense - a unique dietary supplement for the mental capacity

Press release9/24/2024, 11:00 AM

New study strengthens Probi[ ][®]s L. plantarum HEAL9[®] strain in cognitive function

Third party research7/17/2024, 6:29 AM

Probi: FY'24e marks a transition to a promising future - ABG

- Beat on Q2 sales (+3%) and EBITDA (+24%) vs ABGSCe - EBITDA up 2% for '24e and 1% for '25e - Our comprehensive analysis indicates a promising long-term outlook Americas and EMEA progressed well in Q2 Probi reported a strong Q2'24 driven by growth in...

Probi, Audiocast with teleconference, Q2'24

Webcast7/16/2024, 8:00 AM

Probi, Audiocast with teleconference, Q2'24

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.